GW researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America
For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer. Their findings are found in two papers published today in the journal eLife.
“The genes we ‘knocked out’ using CRISPR/Cas9 resulted in markedly diminished symptoms of infection in our animal models,” said Paul Brindley, PhD, professor of microbiology, immunology, and tropical medicine at the GW School of Medicine and Health Sciences, and lead author. “Our research also showed that this revolutionary new biomedical procedure — CRISPR/Cas9 — can be adapted to study helminth parasites, which are a major public health problem in tropical climates.”
CRISPR/Cas9 is a new technology that allows researchers to precisely target and deactivate the genetic information needed to produce a particular protein. While the tool has been used in other species before, it was unknown if it could be applied to Schistosoma mansoni and Opisthorchis viverrini, the parasites responsible for schistosomiasis and liver fluke infection.
Schistosomiasis can cause serious health problems, including damage to the liver and kidneys, infertility and bladder cancer. The freshwater worms S. mansoni enter the human body by burrowing into the skin; once in the bloodstream, they move to various organs where they rapidly start to reproduce. Their eggs release several molecules, including a protein known as omega-1 ribonuclease, which can damage the surrounding tissues. Brindley and his research team “knocked out” this protein using CRISPR/Cas9 and found that it greatly reduced the impact of the disease.
Liver fluke infection can cause a type of liver cancer called bile duct cancer, triggered by the presence of the worm O. viverrini. This parasite is transmitted through traditional Southeast Asian cuisines using uncooked or undercooked fish. Once inside the body, the parasite settles in the human liver and secretes a protein known as granulin that may encourage liver cells to multiply, raising the risk for cancer. Brindley and his research team used CRISPR/Cas9 to deactivate the gene that codes for granulin and create parasites that can only produce very little of the protein, leading to markedly reduced symptoms of liver fluke infection.
“These neglected tropical diseases affect more than a quarter of a billion people primarily living in Southeast Asia, sub-Saharan Africa, and Latin America,” said Brindley. “CRISPR/Cas9 is a tool that may be used to limit the impact of these infections. As we work to better understand how these parasites invade and damage our bodies through this new technology, we will find new ideas for treatment and disease control.”
The Latest on: CRISPR/Cas9
[google_news title=”” keyword=”CRISPR/Cas9″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: CRISPR/Cas9
- Gene Silencing Slashes Cholesterol in Mice—No Gene Edits Requiredon February 29, 2024 at 1:26 pm
With a single shot of an epigenetic editor, the mice’s cholesterol levels rapidly dropped, and stayed low for nearly a year without notable side effects.
- Novel Gene Editing Tool Improves Immune Cell Activityon February 29, 2024 at 8:00 am
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in gene editing. The gene editing techn | Immunology ...
- CRISPR/Cas9-mediated targeted mutagenesis of inulin biosynthesis in rubber dandelionon February 22, 2024 at 1:58 pm
Researchers have leveraged the power of the CRISPR/Cas9 genome editing system to enhance natural rubber production in rubber dandelion (Taraxacum kok-saghyz). The CRISPR system's efficiency and ...
- Junk DNA in birds may hold key to safe, efficient gene therapyon February 20, 2024 at 2:00 am
The recent approval of a CRISPR-Cas9 therapy for sickle cell disease demonstrates that gene editing tools can do a superb job of knocking out genes to cure hereditary disease. But it's still not ...
- Birds’ junk DNA enables UC Berkeley to unlock safe human gene therapyon February 20, 2024 at 2:00 am
CRISPR-Cas9 therapy has recently gained approval for treating sickle cell disease by knocking out specific genes. However, one restriction remains: it cannot presently introduce genes into the human ...
- CRISPR 'will provide cures for genetic diseases that were incurable before,' says renowned biochemist Virginijus Šikšnyson February 19, 2024 at 3:00 am
Live Science spoke with biochemist Virginijus Šikšnys, whose work helped establish CRISPR as a gene-editing system.
- Opinion: The Promise and Challenges of CRISPR-Based Treatmentson February 18, 2024 at 9:10 pm
With last year's approval of Vertex and CRISPR's Casgevy, it's the start of a new era of gene editing. But there are still challenges we must face.
- What's Going On With Crispr Therapeutics Stock?on February 15, 2024 at 8:36 am
Crispr shares are trading higher Thursday after Wolfe Research initiated coverage on Crispr Therapeutics with a Peer Perform rating. Crispr Therapeutics' shares rise ...
- A nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatmenton February 1, 2024 at 7:52 am
I n a study published in MedComm—Biomaterials and Applications Professor Changyang Gong and his Ph.D. student Shiyao Zhou elaborate on the mechanism of CRISPR/Cas9 system. The CRISPR/Cas9 system ...
- A nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatmenton January 31, 2024 at 4:00 pm
CRISPR/Cas9 has many unresolved issues at the molecular level. In conclusion, personalized targeted therapy based on CRISPR/Cas9 may be the future of tumor therapy and bring new hope for tumor ...
via Bing News